When does Mounjaro wear off — and what actually happens across the week?

The myth: Mounjaro stops working after a few days

This is the most common worry our prescribers hear, that the medicine runs out of steam by midweek and the appetite returns because it has "worn off". The pharmacology tells a different story. Tirzepatide is designed to stay active across a full seven-day cycle. Its half-life sits at around five days, which means that even on day seven, a meaningful concentration is still present in your system. You can read more about how the medicine behaves in the days immediately after injection on our page about whether Mounjaro wears off after five days.

What people often interpret as the medicine "running out" is actually a natural pharmacokinetic taper: peak plasma levels arrive roughly 24–72 hours after the injection, and concentrations then decline steadily. That decline does not mean the medicine is absent, it means it is at a lower point in a normal cycle. The NHS patient information for tirzepatide confirms the once-weekly schedule is set specifically to maintain consistent therapeutic activity, and the NHS tirzepatide medicines page is a useful reference for understanding the expected pattern.

Correcting this misconception matters because it prevents people from drawing the wrong conclusion: that they need a higher dose sooner, or that their treatment is failing. Dose decisions sit with the prescriber.

What you are likely feeling toward the end of the week

The appetite-suppressing effect of Mounjaro is real and measurable, but it is not binary. Many people find that fullness cues, reduced cravings and slower gastric emptying feel most pronounced on days one to three after injecting. By days five to seven, those sensations can feel softer. Hunger may nudge back, portion sizes might feel less naturally controlled, and some people notice slightly more fatigue or a change in energy. This is all consistent with the gradual plasma-level decline described above.

It does not mean the medicine is failing. It means you are at the lower end of a weekly cycle, the same pattern repeats after the next injection. If the drop feels significant, what happens at the end of the Mounjaro week covers this in more detail, including practical strategies that complement treatment. Keeping meals protein-rich and maintaining hydration across the full week can help moderate those end-of-week shifts, though personal plans belong with your prescriber or dietitian.

Some people experience a symptom known as "wearing off" more acutely and wonder whether injecting on a different day or adjusting the timing would help. The short answer: the day of injection matters mainly for consistency. Switching days is something to discuss with a prescriber rather than experiment with unilaterally.

When Mounjaro does genuinely wear off: what stopping the medicine looks like

There is a separate and important question buried in this keyword: what happens when tirzepatide is discontinued entirely? This is where the medicine does, in a real clinical sense, "wear off". Unlike an antibiotic that completes a course and its job is done, Mounjaro works by modulating ongoing gut-hormone signalling. When the medicine stops, so does that signalling support. Appetite typically returns to pre-treatment levels over several weeks. Weight regain is common, studies in the broader tirzepatide clinical programme found that most participants who discontinued regained a significant proportion of lost weight within a year.

This is not a flaw or a sign that treatment failed. It reflects the biology of obesity as a chronic condition, which our tirzepatide overview explains in more detail. Whether ongoing or long-term treatment is appropriate is a clinical conversation. For context on how Mounjaro fits within the wider UK landscape of weight-loss options, the weight-loss treatments overview is a good starting point. There is also a separate and sometimes overlooked question about whether the medicine's effects change during the week as treatment progresses, how Mounjaro changes across the treatment weeks covers that pattern specifically.

If you are considering stopping because of side effects, cost pressures or concerns about efficacy, the right move is to raise it with a prescriber before making changes. The NHS guidance on tirzepatide covers what to expect when stopping, and a GPhC-registered prescriber can advise based on your individual clinical picture.

Does this pattern change with dose?

Yes, to a degree. At lower doses (2.5mg and 5mg) the end-of-week tapering effect can feel more noticeable because peak activity is less pronounced to begin with. As the dose increases, many people report that appetite suppression feels more consistent across the full seven days. This is one of the reasons the licensed titration schedule exists: it is calibrated to balance tolerability against meaningful therapeutic effect, not just to move numbers upward. The question of whether Mounjaro wears off during the week varies by dose, and your prescriber tracks how each stage lands for you specifically.

At our Mounjaro information hub, you will find a fuller account of how the titration schedule is structured and what the clinical evidence says about effectiveness at each dose level. Prescribers at nume review your response at every repeat before the next order is processed, not as a box-tick, but as a genuine clinical check. If end-of-week wearing off is affecting your experience, that conversation starts with the consultation. And if you are weighing up whether to begin treatment at all, checking your eligibility is the logical first step.